跳至主要内容
临床试验/ACTRN12614000689673
ACTRN12614000689673终止2 期

The effects of estradiol on bone architecture and fat mass in men with prostate cancer

niversity of Melbourne0 个研究点目标入组 78 人开始时间: 2014年6月30日最近更新:
适应症

试验速览

阶段
2 期
状态
终止
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 No limit 至 o limit(—)
性别
Male

入选标准

  • 1. Men with prostate cancer receiving gonadotropin-releasing hormone agonists or antagonists to suppress androgen production
  • 2. Androgen Deprivation Therapy intended to continue for at least 6 months
  • 3. Able and willing to comply with the study protocol requirements

排除标准

  • 1. Bone metastases within imaging fields detectable by conventional imaging (e.g. CT scanning, bone scanning)
  • 2. Significantly impaired performance status (ECOG > 2)
  • 3. Previous history of deep vein thrombosis or pulmonary embolism
  • 4. Stroke, transient ischaemic attack, myocardial infarction, or angina within the previous 12 months
  • 5. New York Heart Association class 3-4 heart failure
  • 6. Systolic blood pressure of 160 mmHg or higher or diastolic blood pressure of 100 mmHg or higher, or both.
  • 7. Previous history of breast cancer
  • 8. Current oral glucocorticoid therapy
  • 9. Any current or previous antiresorptive therapy
  • 10. Recreational drug use, alcohol dependence, known HIV/AIDS or any disease which is likely to lead to serious illness or death within the study period
  • 11. Inability to understand sufficient English to give informed consent.

研究者

发起方
niversity of Melbourne

相似试验

Biological actions of estradiol in men trial | 临床试验